7 companies in Polaris Partners's investment portfolio.
Back to Polaris Partners profile“Invests in healthcare and technology companies with differentiated approaches to large market opportunities, from seed to growth.”
Precision medicine company developing targeted therapies for cancer and rare diseases using genomics-based drug discovery.
Foundation Medicine, Inc. is an American company based in Boston, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.
Polaris Partners has built a portfolio of 7 companies across 1 sector, including Biotech.
The portfolio reflects investments across the IPO stage, showing Polaris Partners's approach to supporting companies at a focused stage of development.
Polaris Partners has invested in 7+ companies across 1 different sectors.
Polaris Partners's portfolio spans Biotech. This diversification reflects the firm's broad investment thesis and sector expertise.
Polaris Partners invests across the IPO stage. Their portfolio includes companies at various points in their growth journey.